AZD-5672

DB11804InvestigationalSmall molecule

Azd5672 has been used in trials studying the basic science and treatment of Pharmacokinetics, Renal Impairment, and Rheumatoid Arthritis.

Mechanism: Pharmacologically active on C-C chemokine receptor type 5
Curator reviewed
Formula / weight: C₃₂H₃₈F₂N₂O₅S₂ · 632.78 g/mol (avg)
Code names: AZD5672

Resolves to

Compound

Structure

InChIKeySCXSQUUTGCWHFU-WJOKGBTCSA-NSMILESCCN(C1CCN(CC[C@H](C2=CC=C(C=C2)S(C)(=O)=O)C2=CC(F)=CC(F)=C2)CC1)C(=O)CC1=CC=C(C=C1)S(C)(=O)=O

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with AZD-5672, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.